Bhattarai, SanjeetKarthak, AshishGurung, NareshShrestha, AshishLama, RakeshBhusal, YuvarajGiri, BijayChhetri, SujanShrestha, Sanjeet Krishna2026-02-032026-02-032022https://hdl.handle.net/20.500.14572/4472Sanjeet Bhattarai Department of Pulmonary, Critical Care Medicine and Sleep Medicine, Nepal Mediciti Hospital Ashish Karthak Department of Pulmonary, Critical Care Medicine and Sleep Medicine, Nepal Mediciti Hospital Naresh Gurung Department of Pulmonary, Critical Care Medicine and Sleep Medicine, Nepal Mediciti Hospital Ashish Shrestha Department of Pulmonary, Critical Care Medicine and Sleep Medicine, Nepal Mediciti Hospital Rakesh Lama Department of Pulmonary, Critical Care Medicine and Sleep Medicine, Nepal Mediciti Hospital Yuvaraj Bhusal Department of Pulmonary, Critical Care Medicine and Sleep Medicine, Nepal Mediciti Hospital Bijay Giri Sandwell General Hospital –NHS trust Sujan Chhetri Department of Otorhinolaryngology department, Nepal Mediciti Hospital Sanjeet Krishna Shrestha Department of Pulmonary, Critical Care Medicine and Sleep Medicine, Nepal Mediciti HospitalAbstract: With the second wave of COVID-19, there was a surge of cases of mucormycosis co-infection in our health center. We would like to present a case of a 53 years old man with COVID-19 positive status who later developed mucormycosis, with invasion of Maxillary sinus, jugular vein, digastric recess in MRI. He was managed with Amphotericin –B injection along with insulin therapy in sliding scale and Posaconazole thereafter for six months. Debridement of the lesion was done along with removal of inferior alveolar process of maxillary process and 3 molar teeth and a premolar tooth of upper left side.en-USCOVID-19DebridementMaxillary SinusMucormycosisArticle